AiViva Presenting at OIS 2025 - San Diego, CA
2025-11-21 - 2025-11-22 | IL
Where collaboration is driven by a deep sense of commitment to learn and share game-changing therapies in ophthalmology, Ophthalmology Innovation Source (OIS) gives the opportunity to network where extraordinary things happen when the right people connect!
Join AiViva at OIS as our CEO, Dr. Diane Tang-Liu, as she presents “AIV007 in nAMD and DME Results” on Saturday, November 22, 2025.
Diane and our Head of Business Development, Agustin de la Calle, will be happy to meet you at this networking event. If you are interested in meeting these two dynamic executives, reach out to Agustin at agustindlc@aiviva.com.
For more information on OIS: Ophthalmology Innovation Source

To listen to Dr. Tang-Liu’s 2024 OIS speaking event, click here:

2024 OIS Presentation Recording by Dr. Diane Tang-Liu, CEO *

∗ Disclaimer: Investigational product; early-stage data; not for promotional use.

AiViva Presenting at ATF 2026 Powered by Octane
2026-01-08 - 2026-01-09
AiViva BioPharma is pleased to join Octane Aesthetics Tech Forum this January 8–9, 2026 in Newport Beach as a Presenting Company. Diane Tang-Liu, CEO and President, is AiViva’s representative as well as Agustin de la Calle, Vice President of Business Development.
We look forward to discussions around AIV001, a clinical-stage dermatology program currently under evaluation in Phase I/IIa clinical studies.
In Phase I/IIa clinical studies, AIV001 is being evaluated as an investigational dermatology program in indications related to fresh and established scar modulation and exploratory approaches to surgical-free management of low-risk basal cell carcinoma (BCC), with assessments including safety, tolerability, histologic findings, and cosmetic outcomes.
Contact Agustin for appointments to meet with this dynamic duo: agustindlc@aiviva.com
https://www.octane-oc.org/event/atf2026/agenda
www.aiviva.com

UPDATE:
To listen to Dr. Tang-Liu’s 2026 ATF speaking event, click on link below:

2026 ATF Presentation Recording by Dr. Diane Tang-Liu, CEO *

∗ Disclaimer: Investigational product; early-stage data; not for promotional use.

44th Annual J.P. Morgan Healthcare Conference
2026-01-12 - 2026-01-15
AiViva BioPharma excited to meet executives participating at the J.P.Morgan Healthcare Conference in San Fransico. Diane Tang-Liu, CEO, and Agustin de la Calle, Vice President of Business Development will be available to meet while in San Francisco during this time.
Contact Agustin to schedule a time to meet: agustindlc@aiviva.com
For more information, visit: https://www.jpmorgan.com/about-us/events-conferences/health-care-conference
www.aiviva.com

2026 BIO-Europe Spring Conference
2026-03-23 - 2026-03-25
Agustin de la Calle, Vice President of Business Development for AiViva BioPharma, Inc., is attending the BIO-Europe Spring 2026 conference, Europe’s largest springtime biotech partnering event, in Lisbon, Portugal, from March 23 to 25, 2026. The conference will gather thousands of professionals, investors, and innovative companies from the global life sciences ecosystem to foster collaboration, discuss clinical development strategies, and explore new partnership opportunities.
The in-person event will be held at the FIL (Feira Internacional de Lisboa) exhibition and congress center and includes workshops, panel discussions, and one-to-one meetings designed to drive collaboration and business development. Agustin looks forward to connecting with industry peers and contributing to the conversation on the new wave of biotech innovation.
If you are attending and would like to schedule a meeting to discuss potential collaborations or industry insights, feel free to reach out to Agustin directly at agustindlc@aiviva.com, or book a slot via the PartneringONE platform.
Learn more at: https://informaconnect.com/bioeurope-spring/
www.aiviva.com

2026 Fierce Pharma Engage
2026-04-22 - 2026-04-24
AiViva is participating in Fierce Pharma Engage 2026 in San Diego!
Fierce Pharma Engage 2026 is the premier West Coast cross-functional event for the life sciences industry, taking place from April 22–24, 2026, in San Diego, CA.
Join our Vice President of Business Development, Agustin de la Calle, PhD, as he explores potential collaborations with other innovative, pharma companies on emerging trends on advanced technologies and scientific innovations.
Key Highlights

Location:Hilton San Diego Bayfront.
Focus:Cross-functional collaboration, aligning scientific messaging, and positioning Medical Affairs strategically.
Experience:Features interactive sessions, personalized 1:1 meetings via Fierce Pharma Connect, and networking events like a sunset cruise.

For more details, visit the official website or LinkedIn page.
www.aiviva.com

Effective May 1, 2026
2026-04-30 - 2026-05-01
______________________________________________
We are pleased to share that AiViva has moved to a new office in Newport Beach.
Stop by and visit anytime!

Find AiViva at 2026 BIO International Convention
2026-06-22 - 2026-06-25
Looking forward to attending BIO International Convention 2026 in San Diego and meeting colleagues across the biotech, pharmaceutical, investment, academic, nonprofit, and government communities.
At AiViva BioPharma, we are advancing two clinical-stage programs:

AIV007, a periocular, sustained-release lenvatinib therapy being developed for retinal vascular diseases, including wet AMD and DME.
AIV001, an intradermally administered axitinib therapy being investigated for scar management and non-melanoma skin cancer.

Both programs are supported by human clinical data and leverage our proprietary JEL™ localized drug-delivery technology designed to provide sustained exposure while minimizing systemic drug levels.
We welcome discussions regarding strategic partnerships, regional licensing, co-development opportunities, and potential investment relationships.
If you will be attending BIO 2026, I would be pleased to connect.
